Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06718907 · ClinicalTrials.gov registry record · NA

Mitigating Response to Stressors in Pregnant Women

A NA study of Pregnancy, sponsored by Nova Southeastern University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06718907 is a NA study of Pregnancy that is actively recruiting participants, run by Nova Southeastern University. The registered enrollment target is 50 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06718907, a NA study of Pregnancy, is actively recruiting participants, sponsored by Nova Southeastern University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Stress-induced pregnancy complications are significant contributors to preterm labor as well as maternal and perinatal morbidity and mortality. The goals of this study are two folds: first it aims to capture the pregnant woman's journey to seek and receive prenatal care. Second, this study aims to develop models that 1) assess the adverse health and biological effects of social factors on pregnant women who experience repeated or chronic stress, 2) address how stress can be mitigated in pregnant women from different backgrounds who experience high stress.

Conditions Studied

Interventions

  • BEHAVIORAL Stress Management
  • BEHAVIORAL Simulated stimuli

Study Locations (1)

Florida

  • Nova Southeastern University - Davie

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-12-20
Est. Completion 2026-12-31
Phase NA

Sponsor

Nova Southeastern University

71 total trials

What the Registry Record Tells You About NCT06718907

The ClinicalTrials.gov registry entry for NCT06718907 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower). The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Stress Management is the first listed.

NCT06718907 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06718907 about?

NCT06718907 is a clinical study titled "Mitigating Response to Stressors in Pregnant Women". Stress-induced pregnancy complications are significant contributors to preterm labor as well as maternal and perinatal morbidity and mortality. The goals of this study are two folds: first it aims to capture the pregnant woman's journey to seek and receive prenatal care. Second, this study aims to d...

What is the current status of trial NCT06718907?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-12-20. Estimated completion is 2026-12-31.

What conditions does trial NCT06718907 study?

This clinical trial studies the following conditions: Pregnancy.

What interventions are being tested in trial NCT06718907?

The interventions under investigation include: Stress Management (BEHAVIORAL), Simulated stimuli (BEHAVIORAL).

Who is sponsoring clinical trial NCT06718907?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06718907 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.